International Journal of Antimicrobial Agents
Volume 35, Issue 4 , Pages 366-374 , April 2010

Synergistic effects of dexamethasone and quinolones on human-derived tendon cells

  • Judith Sendzik

      Affiliations

    • Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Garystr. 5, 14195 Berlin, Germany
    • ,
  • Mehdi Shakibaei

      Affiliations

    • Institute of Anatomy, Ludwig–Maximilians–Universität München, Pettenkoferstr. 11, 80336 München, Germany
    • ,
  • Monika Schäfer-Korting

      Affiliations

    • Institute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, Königin-Luise-Str. 2–4, 14195 Berlin, Germany
    • ,
  • Hartmut Lode

      Affiliations

    • Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Garystr. 5, 14195 Berlin, Germany
    • ,
  • Ralf Stahlmann

      Affiliations

    • Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Garystr. 5, 14195 Berlin, Germany
    • Corresponding Author InformationCorresponding author.

Received 28 July 2009 ,Accepted 6 October 2009.

References 

  1. van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs. 2007;67:2355–2382
  2. Smith AG, Kosygan K, Williams H, Newman RJ. Common extensor tendon rupture following corticosteroid injection for lateral tendinosis of the elbow. Br J Sports Med. 1999;33:423–424
  3. Hayes DW, Gilbertson EK, Mandracchia VJ, Dolphin TF. Tendon pathology in the foot. The use of corticosteroid injection therapy. Clin Podiatr Med Surg. 2000;17:723–735
  4. van der Linden PD, van de Lei J, Nab HW, Knol A, Stricker BH. Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol. 1999;48:433–437
  5. van der Linden PD, van Puijenbroek EP, Feenstra J, Veld BA, Sturkenboom MC, Herings RM, et al. Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum. 2001;45:235–239
  6. van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HG, Stricker BH. Fluoroquinolones and risk of Achilles tendon disorders: case–control study. BMJ. 2002;324:1306–1307
  7. van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HM, Rowlands S, Stricker BH. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med. 2003;163:1801–1807
  8. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003;36:1404–1410
  9. Stahlmann R. Effects on connective tissue structures. In:  Hooper D,  Rubinstein E editor. Quinolone antimicrobial agents. 3rd ed.. Washington, DC: ASM Press; 2002;p. 441–449
  10. Sendzik J, Lode H, Stahlmann R. Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data. Int J Antimicrob Agents. 2008;33:194–200
  11. Huston KA. Achilles tendinitis and tendon rupture due to fluoroquinolone antibiotics. N Engl J Med. 1994;331:748
  12. Zabraniecki L, Negrier I, Vergne P, Arnaud M, Bonnet C, Bertin P, et al. Fluoroquinolone induced tendinopathy: report of 6 cases. J Rheumatol. 1996;23:516–520
  13. Braun D, Petitpain N, Cosserat F, Loeuille D, Bitar S, Gillet P, et al. Rupture of multiple tendons after levofloxacin therapy. Joint Bone Spine. 2004;71:586–587
  14. Barge-Caballero E, Crespo-Leiro MG, Paniagua-Martín MJ, Muñiz J, Naya C, Bouzas-Mosquera A, et al. Quinolone-related Achilles tendinopathy in heart transplant patients: incidence and risk factors. J Heart Lung Transplant. 2008;27:46–51
  15. Tozer S, Duprez D. Tendon and ligament: development, repair and disease. Birth Defects Res C Embryo Today. 2005;75:226–236
  16. Bernard-Beaubois K, Hecquet C, Houcine O, Hayem G, Adolphe M. Culture and characterization of juvenile rabbit tenocytes. Cell Biol Toxicol. 1997;13:103–113
  17. Schulze-Tanzil G, Mobasheri A, Clegg PD, Sendzik J, John T, Shakibaei M. Cultivation of human tenocytes in high-density culture. Histochem Cell Biol. 2004;122:219–228
  18. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028–1032
  19. van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001;305:285–298
  20. Yang C, Li SW, Helminen HJ, Khillan JS, Bao Y, Prockop DJ. Apoptosis of chondrocytes in transgenic mice lacking collagen II. Exp Cell Res. 1997;235:370–373
  21. Shakibaei M, Schulze-Tanzil G, de Souza P, John T, Rahmanzadeh M, Rahmanzadeh R, et al. Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes. J Biol Chem. 2001;276:13289–13294
  22. Shakibaei M, Pfister K, Schwabe R, Stahlmann R. Effects of ofloxacin on the ultrastructure of Achilles tendon in rats. Drugs. 1999;58(Suppl. 2):390–392
  23. Shakibaei M, Stahlmann R. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch Toxicol. 2001;75:97–102
  24. Shakibaei M, de Souza P, van Sickle D, Stahlmann R. Biochemical changes in Achilles tendon from juvenile dogs after treatment with ciprofloxacin or feeding a magnesium-deficient diet. Arch Toxicol. 2001;75:369–374
  25. Sendzik J, Shakibaei M, Schäfer-Korting M, Stahlmann R. Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology. 2005;212:24–36
  26. Almekinders LC, Deol G. The effects of aging, antiinflammatory drugs, and ultrasound on the in vitro response of tendon tissue. Am J Sports Med. 1999;27:417–421
  27. Wong MW, Tang YY, Lee SK, Fu BS, Chan BP, Chan CK. Effect of dexamethasone on cultured human tenocytes and its reversibility by platelet-derived growth factor. J Bone Joint Surg Am. 2003;85:1914–1920
  28. Wong MW, Tang YN, Fu SC, Lee KM, Chan KM. Triamcinolone suppresses human tenocyte cellular activity and collagen synthesis. Clin Orthop Relat Res. 2004;421:277–281
  29. Wong MW, Tang YY, Lee SK, Fu BS. Glucocorticoids suppress proteoglycan production by human tenocytes. Acta Orthop. 2005;76:927–931
  30. Torricelli P, Fini M, Giavaresi G, Carpi A, Nicolini A, Giardino R. Effects of systemic glucocorticoid administration on tenocytes. Biomed Pharmacother. 2006;60:380–385
  31. Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44:61–98
  32. van Zanten AR, Polderman KH, van Geijlswijk IM, van der Meer GY, Schouten MA, Girbes AR. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study. J Crit Care. 2008;3:422–430
  33. Dudley MN. Pharmacokinetics of fluoroquinolones. In:  Hooper DE,  Rubinstein E editor. Quinolone antimicrobial agents. 3rd ed.. Washington, DC: ASM Press; 2002;p. 115–132
  34. Chow AT, Fowler C, Williams RR, Morgan N, Kaminski S, Natarajan J. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers. Antimicrob Agents Chemother. 2001;45:2122–2125
  35. Oikarinen AI, Vuorio EI, Zaragoza EJ, Palotie A, Chu ML, Uitto J. Modulation of collagen metabolism by glucocorticoids. Receptor-mediated effects of dexamethasone on collagen biosynthesis in chick embryo fibroblasts and chondrocytes. Biochem Pharmacol. 1988;37:1451–1462
  36. Oikarinen A, Makela J, Vuorio T, Vuorio E. Comparison on collagen gene expression in the developing chick embryo tendon and heart. Tissue and development time-dependent action of dexamethasone. Biochim Biophys Acta. 1991;1089:40–46
  37. Scutt N, Rolf CG, Scutt A. Glucocorticoids inhibit tenocyte proliferation and tendon progenitor cell recruitment. J Orthop Res. 2006;24:173–182
  38. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990;6:121–125
  39. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–21494
  40. Riley GP, Curry V, DeGroot J, van El B, Verzijl N, Hazleman BL, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 2002;21:185–195
  41. Ritty TM, Herzog J. Tendon cells produce gelatinases in response to type I collagen attachment. J Orthop Res. 2003;21:442–450
  42. Sadowski T, Steinmeyer J. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Osteoarthritis Cartilage. 2001;9:407–415
  43. Stöve J, Schöniger R, Huch K, Brenner R, Günther KP, Puhl W, et al. Effects of dexamethasone on proteoglycan content and gene expression of IL-1β-stimulated osteoarthrotic chondrocytes in vitro. Acta Orthop Scand. 2002;73:562–567
  44. Boileau C, Pelletier JP, Tardif G, Fahmi H, Laufer S, Lavigne M, et al. The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway. Ann Rheum Dis. 2005;64:891–898
  45. Nakazawa F, Matsuno H, Yudoh K, Watanabe Y, Katayama R, Kimura T. Corticosteroid treatment induces chondrocyte apoptosis in an experimental arthritis model and in chondrocyte cultures. Clin Exp Rheumatol. 2002;20:773–781
  46. Chrysis D, Ritzen EM, Savendahl L. Growth retardation induced by dexamethasone is associated with increased apoptosis of growth plate chondrocytes. J Endocrinol. 2003;176:331–337
  47. Van Offel JF, Schuerwegh AJ, Bridts CH, Stevens WJ, De Clerck LS. Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. Ann Rheum Dis. 2002;61:925–928
  48. Kempka G, Ahr HJ, Rüther W, Schlüter G. Effects of fluoroquinolones and glucocorticoids on cultivated tendon cells in vitro. Toxicol In Vitro. 1996;10:743–754
  49. Kashida Y, Kato M. Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds. Antimicrob Agents Chemother. 1997;41:2389–2393
  50. Chhajed PN, Plit ML, Hopkins PM, Malouf MA, Glanville AR. Achilles tendon disease in lung transplant recipients: association with ciprofloxacin. Eur Respir J. 2002;19:469–471

PII: S0924-8579(09)00483-X

doi: 10.1016/j.ijantimicag.2009.10.009

International Journal of Antimicrobial Agents
Volume 35, Issue 4 , Pages 366-374 , April 2010

Article Tools

* Image Usage & Resolution